Frances Johnson, a medical doctor and chief innovation officer at Perspective Therapeutics, and Michael Schultz, a Ph.D. and the company’s chief science officer, are shown Oct. 1 at the company’s ...
LONDON, UK, 4 March 2025 - In a comprehensive Genomic Press Viewpoint (review) article, researchers are shining a spotlight on a revolutionary approach to tackling neuroendocrine tumours (NETs), a ...
Perspective Therapeutics' pipeline, led by VMT-a-NET, shows promising safety and early efficacy, but lacks clear superiority over existing therapies like Lutathera so far. The company maintains a ...
Perspective Therapeutics' novel alpha emitter PRRT shows promise in early trials, with manageable toxicity and durable disease control in GEP-NETs and melanoma. Strong cash position allows CATX to ...
Plasma Channel on MSN
Detecting radiation using high voltage plasma (spark detector)
Bringing light to the invisible, this spark detector takes advantage of Alpha radiation's tendency to ionize air. Add 6,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback